Insider Selling: Steris PLC (NYSE:STE) Director Sells 5,854 Shares of Stock

Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 5,854 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $153.77, for a total value of $900,169.58. The sale was disclosed in a document filed with the SEC, which is available through this link.

Richard Martin Steeves also recently made the following trade(s):

  • On Monday, December 2nd, Richard Martin Steeves sold 5,960 shares of Steris stock. The shares were sold at an average price of $150.75, for a total value of $898,470.00.

Shares of NYSE:STE opened at $152.95 on Friday. The firm has a 50 day moving average of $146.09 and a 200-day moving average of $145.77. Steris PLC has a 12 month low of $99.14 and a 12 month high of $156.66. The company has a current ratio of 2.41, a quick ratio of 1.86 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $12.81 billion, a PE ratio of 31.28 and a beta of 0.89.

Steris (NYSE:STE) last posted its quarterly earnings results on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.26 by $0.06. The business had revenue of $736.84 million for the quarter, compared to analyst estimates of $717.79 million. Steris had a net margin of 11.59% and a return on equity of 16.15%. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter last year, the business posted $1.10 EPS. On average, research analysts predict that Steris PLC will post 5.6 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Tuesday, November 26th will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Monday, November 25th. Steris’s payout ratio is presently 30.27%.

Separately, ValuEngine lowered Steris from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $148.20.

Hedge funds have recently modified their holdings of the business. Squar Milner Financial Services LLC raised its holdings in shares of Steris by 225.9% during the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 122 shares in the last quarter. Ropes Wealth Advisors LLC acquired a new stake in Steris in the second quarter valued at about $26,000. Quest Capital Management Inc. ADV bought a new position in Steris in the third quarter valued at about $26,000. Krane Funds Advisors LLC acquired a new position in Steris during the second quarter worth about $27,000. Finally, CWM LLC raised its stake in Steris by 130.9% during the third quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 106 shares in the last quarter. 86.77% of the stock is currently owned by hedge funds and other institutional investors.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Day Trading

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with's FREE daily email newsletter.